Cited 8 times in
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.